EDIT Stock Summary and Trading Ideas (Editas Medicine | NASDAQ:EDIT)

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Editas Medicine trades on the NASDAQ stock market under the symbol EDIT.

As of March 5, 2025, EDIT stock price climbed to $2.05 with 8,894,766 million shares trading.

EDIT has a beta of 1.72, meaning it tends to be more sensitive to market movements. EDIT has a correlation of 0.07 to the broad based SPY ETF.

EDIT has a market cap of $169.08 million. This is considered a Micro Cap stock.

Last quarter Editas Medicine reported $61,000 in Revenue and -$.75 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.03.

In the last 3 years, EDIT traded as high as $21.60 and as low as $1.12.

The top ETF exchange traded funds that EDIT belongs to (by Net Assets): IWM, VTI, VXF, IWN, IBB.

EDIT has underperformed the market in the last year with a return of -79.3%, while SPY returned +15.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in EDIT shares. However, EDIT has outperformed the market in the last 3 month and 2 week periods, returning +3.0% and +17.8%, while SPY returned -3.7% and -4.6%, respectively. This indicates EDIT has been having a stronger performance recently.

EDIT support price is $1.61 and resistance is $1.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EDIT shares will trade within this expected range on the day.